Äkillisen välikorvatulehduksen hoito -tutkimus.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-005964-10-FI

Enrollment

400

Registered

2005-12-28

Start date

2006-02-17

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lääkärin toteama äkillinen välikorvatulehdus

Interventions

Trade Name: Augmentin tabletti 875 mg Pharmaceutical Form: Oral powder INN or Proposed INN: amoksisilliini Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 875- INN

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026